Compare
BlueLinx Holdings Inc. vs Boise Cascade Co vs QXO, Inc. vs Aspen Aerogels Inc
| Latest fiscal year | BlueLinx Holdings Inc. BXC | Boise Cascade Co BCC | QXO, Inc. QXO | Aspen Aerogels Inc ASPN |
|---|---|---|---|---|
| Year ended | 2026-01-03 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $2.95B | $6.40B | $6.84B | $271.10M |
| Revenue growth (YoY) | 0.0% | -4.8% | n/m | -40.1% |
| Gross margin | 15.3% | n/a | 23.0% | 17.0% |
| Operating margin | 1.1% | 2.9% | -3.6% | -139.5% |
| Net margin | 0.0% | 2.1% | -4.1% | -143.7% |
| Net income | $219.0K | $132.84M | -$279.40M | -$389.55M |
| EPS (Diluted) | $0.02 | $3.53 | -$0.63 | -$4.73 |
| Operating cash flow | $59.78M | $254.15M | $261.40M | $32.87M |
| Free cash flow | $32.85M | $12.72M | $183.20M | -$4.58M |
| Cash & equivalents | $385.84M | $477.21M | $2.36B | $156.86M |
| Total assets | $1.55B | $3.24B | $15.89B | $406.68M |
| Total liabilities | $931.96M | n/a | $6.18B | $171.16M |
| Shareholders' equity | $617.32M | $2.07B | $9.71B | $235.52M |
| Return on year-end equity | 0.0% | 6.4% | -2.9% | -165.4% |
| Shares outstanding | 7.87M | 36.19M | 674.50M | 82.71M |
Revenue, most recent five fiscal years
| Fiscal year | BlueLinx Holdings Inc. | Boise Cascade Co | QXO, Inc. | Aspen Aerogels Inc |
|---|---|---|---|---|
| Latest | $2.95B Ended 2026-01-03 | $6.40B Ended 2025-12-31 | $6.84B Ended 2025-12-31 | $271.10M Ended 2025-12-31 |
| 1 year earlier | $2.95B Ended 2024-12-28 | $6.72B Ended 2024-12-31 | $56.90M Ended 2024-12-31 | $452.70M Ended 2024-12-31 |
| 2 years earlier | $3.14B Ended 2023-12-30 | $6.84B Ended 2023-12-31 | $54.52M Ended 2023-12-31 | $238.72M Ended 2023-12-31 |
| 3 years earlier | $4.45B Ended 2022-12-31 | $8.39B Ended 2022-12-31 | n/a | $180.36M Ended 2022-12-31 |
| 4 years earlier | $4.28B Ended 2022-01-01 | $7.93B Ended 2021-12-31 | n/a | $121.62M Ended 2021-12-31 |